Best Healthcare Stocks in the United Kingdom for 2026

Pharma, biotech, managed care, and devices, screened with Health and Quality pillars weighted above headline growth to filter out cash-burning outliers.

Healthcare ranges from pharma and biotech to managed care and devices. Pre-revenue biotechs distort sector averages on growth and quality factors, so the composite score weights Health (balance-sheet runway) and Quality (margin durability) higher than headline growth. The "growing fast while burning cash" pattern gets filtered down by the Health pillar.

United Kingdom listings on the London Stock Exchange (LSE) report under IFRS, which makes their Quality and Health pillar inputs (interest coverage, current ratio) directly comparable to other developed markets. Universe filters apply a minimum 5p share price and £200M market cap.

Data as of (updated daily)

Top 20 Healthcare in United Kingdom by composite score

#TickerNameComposite
1TSTL.LSETristel64.7
2SN.LSESmith & Nephew PLC62.0
3TRLS.LSETrellus Health plc61.7
4GNS.LSEGenus PLC61.1
5CRW.LSECraneware Plc60.9
6KNB.LSEKanabo Group PLC60.8
7AOTI.LSEAOTI Inc60.3
8KOO.LSEKooth plc58.6
9IDHC.LSEIntegrated Diagnostics Holdings PLC57.6
10AZN.LSEAstraZeneca PLC57.4
11SPEC.LSEInspecs Group plc57.2
12SUN.LSESurgical Innovations Group plc56.6
13HIK.LSEHikma Pharmaceuticals PLC56.0
14HVO.LSEhVIVO plc55.5
15NFX.LSENuformix plc55.5
16PXS.LSEProvexis plc55.4
17RUA.LSERua Life Sciences PLC55.1
18PYC.LSEPhysiomics Plc54.4
19UPR.LSEUniphar Group PLC54.4
20BVXP.LSEBioventix54.3

Drill into Healthcare stocks in United Kingdom

The full screener applies both filters and lets you stack 30+ more on top: market cap, dividend yield, and the four pillar scores.

Open in screener →

Methodology: How we score stocks. Data refreshed nightly around 03:30 ET. This page lists the top 20 by composite score within the Healthcare sector listed in the United Kingdom; use the screener for the full ranked list.

By using ShareValue.ai you agree to our Terms and Privacy Policy. Educational platform, not investment advice.